Gabelli Funds’s NxStage Medical Inc. NXTM Stock Holding History

Gabelli Funds’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-310,029	Closed	-$8.87M	–	1206
2018 Q4	$8.87M	Buy	310,029 +56,327	+22%	+$1.6M	0.06%	374
2018 Q3	$7.08M	Buy	253,702 +300	+0.1%	+$8.44K	0.04%	473
2018 Q2	$7.07M	Buy	253,402 +10,678	+4%	+$286K	0.04%	467
2018 Q1	$6.03M	Buy	242,724 +19,400	+9%	+$472K	0.04%	502
2017 Q4	$5.41M	Buy	223,324 +44,311	+25%	+$1.17M	0.03%	545
2017 Q3	$4.94M	Buy	+179,013	New	+$4.77M	0.03%	563

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Gabelli Funds's NXTM Position: Q1 2019 in Review

Gabelli Funds sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 310,029 shares — an estimated $8.87M sold.

Gabelli Funds first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $8.87M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Gabelli Funds reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Gabelli Funds sold 310,029 NxStage Medical Inc. shares in Q1 2019, an estimated $8.87M.
Gabelli Funds first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Gabelli Funds's NxStage Medical Inc. position peaked at $8.87M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Gabelli Funds's 13F filing for Q1 2019, filed 2 May 2019.